Health and Healthcare

Grifols : GRFS

GRFS

Stock Data

$7.94

$0.11 (1.40%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.

Latest Activity

GRFSGrifols SA

Q2 2026

Jun 18, 4:00pm ET

Company Update

Grifols shareholders blessed a 10% share buyback and authorized a potential NASDAQ listing, moving to turbocharge earnings per share while Wall Street awaits Q2 results against a $0.28 consensus.

ShareRead more

All Grifols Articles

4 Articles

Lee Jackson | Jul 17, 2015 at 9:05 AM EDT

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings…

Trey Thoelcke | Nov 22, 2013 at 7:00 AM EST

Novartis Announces Share Buybacks and Business Expansion

ThinkstockSpeculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in…

Trey Thoelcke | Nov 11, 2013 at 7:30 AM EST

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ:…

Jon C. Ogg | Aug 15, 2011 at 6:08 PM EDT

John Paulson’s Big Stock Changes (BAC, C, AEM, AU, COF, GFI, GRFS, JPM, LIFE, NYX, RAH, THC, WFC, GLD, NWSA)

Billionaire and hedge fund manager John Paulson of Paulson & Co. and of Paulson Management is a widely followed equity…